CD274 and neoplasm: However, the immune TME in LS is highly dynamic, shaped by factors such as immune checkpoint expression (e.g., PD-1/PD-L1), stromal interactions, and tumor-induced immunosuppression, which can modulate the efficacy of immune responses.12